Skip to main content

Neuroone Medical Technologies Corp

NMTC
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001500198

In the last 90 days, Neuroone Medical Technologies Corp insiders filed 1 open-market purchase and 0 sales; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.21M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Neuroone Medical Technologies Corp changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of NMTC: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders1931+12
Shares3.10M14.4M+11.4M (+366.7%)
Value$2.63M$9.80M+$7.17M (+272.3%)

New holders (14)

Institutions that held Neuroone Medical Technologies Corp at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to NMTC in Q2 2025
InstitutionSharesValue% of portfolio
Bleichroeder LP4,000,000$2.71M0.67%
Sio Capital Management, LLC3,523,663$2.39M0.96%
Bard Associates Inc1,854,600$1.26M0.40%
Perkins Capital Management Inc1,500,000$1.02M1.02%
Renaissance Technologies LLC468,900$318.1K0.00%
XTX Topco Ltd75,634$51.3K0.00%
Warberg Asset Management LLC40,000$27.1K0.01%
HRT Financial LP20,181$13.0K0.00%
Corsair Capital Management, L.P.18,094$12.3K0.00%
Raymond James Financial Inc14,850$10.1K0.00%
AQR Capital Management LLC10,468$7.10K0.00%
Mariner, LLC10,468$7.10K0.00%
Tower Research Capital LLC (TRC)8,629$5.85K0.00%
SBI Securities Co., Ltd.20$140.00%

Sold out (2)

Institutions that held Neuroone Medical Technologies Corp at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of NMTC in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Goldman Sachs Group Inc98,573$83.8K
JPMorgan Chase & Co61$52